|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 555 WEST 57TH STREET |
Address2 |
|
| City | NEW YORK |
State | NY |
Zip Code | 10019 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 16830-12
|
||||||||
|
6. House ID# 324950000
|
||||||||
| TYPE OF REPORT | 8. Year | 2025 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Jonathan Cooper |
Date | 1/20/2026 1:33:26 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Advocate for proposals to provide direct financial support to safety net hospitals with Congressional staff.
Oppose changes to Affordable Care Act in H.R.1: limitations on premium tax credit eligibility, reductions to special enrollment period.
Urge legislative delay of premium tax credit eligibility restrictions included in H.R. 1.
Discuss support for permanently extending expiring Affordable Care Act premium tax credits with Congressional staff.
Discuss 340B Drug Pricing Program with Congressional staff and discuss certain changes: oppose 340B ACCESS Act, comments on SUSTAIN 340B Act discussion draft, support PATIENTS Act, oppose HRSA back-end rebate pilot program.
Discuss with HHS staff and Congressional staff recommendations to address workforce shortages for nursing and ancillary health care workforce: faculty recruitment and retention, additional financial support for supervision and precepting students, Medicare payment for nursing and allied health, testing new workforce models, establishing incentives and early recruitment strategies, providing funding for clinical training sites, and immigration reforms that expedite entry for foreign health care workers.
Support passage of the SAVE Healthcare Workers Act (H.R. 3178/S. 1600).
Support revisions to Conrad 30 waiver program to increase the number of foreign physicians that may remain in the US after completing GME: S.665/H.R.4942, S.2719/H.R.6980, H.R. 4875.
Discuss FEMA COVID-19 Public Assistance payouts with Congressional staff.
Support Improving Seniors Timely Access to Care Act (S. 4532/H.R. 8702).
Support SEPSIS Act (S.1929).
Discuss New York State application for Section 1331 Basic Health Plan waiver with Congressional staff and CMS staff.
Discuss Section 1332 State Innovation Waiver with Congressional staff.
Discuss legislative proposals to regulate the use of artificial intelligence in health care settings.
Discuss non-profit tax-exempt status of hospitals with Congressional staff and discuss examples of community benefit for IRS purposes.
Discuss support for Hospital Preparedness Program funding with Congressional staff.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Alfredo |
|
|
|
Jonathan |
Cooper |
|
|
|
Genny |
Glembotzky |
|
|
|
Timothy |
Johnson |
|
|
|
Puja |
Khare |
|
|
|
Emily |
Leish |
|
|
|
Kenneth |
Raske |
|
|
|
Elisabeth |
Wynn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Discuss with Congressional staff and HHS staff support for Medicare GME expansion and changes to GME program: the Resident Physician Shortage Reduction Act, the Pathway to Practice Act of 2021, the Substance Use Disorder Workforce Act, additional GME slots in CAA, 2021 and CAA, 2023; Rural Residency Planning and Development Act.
Discuss technical amendment to CAA, 2021, Sec. 131 to address artificially low GME caps with Congressional staff.
Discuss with Congressional staff distribution methodology for Medicare GME slots created in the CAA, 2021.
Discuss rural reclassification for Medicare wage index and Medicare GME purposes with Congressional staff.
Discuss COVID-19 Public Health Emergency (PHE) Medicare flexibilities with Congressional staff and HHS staff and support legislative proposals to permanently extend PHE telehealth flexibilities and five-year extension of Acute Hospital Care at Home Waiver.
Discuss opposition to Medicare site-neutral payment policies with Congressional staff.
Oppose changes to NPIs for hospital outpatient departments.
Discuss Transforming Episodic Accountability Model and AHEAD Model with Congressional staff.
Discuss CY 2026 OPPS final rule with Congressional staff: 340B drug acquisition survey, opposition to site-neutral cuts for drug administration services.
Support Medicare Advantage prior authorization reforms - Improving Seniors Timely Access to Care Act (H.R. 3514/S. 1816).
Discuss Medicare wage index issues with CMS.
Discuss proposals that stabilize long-term care and post-acute care providers: establish a temporary per diem Medicare payment to ease capacity issues and address financial challenges from slow discharges (support), make permanent three-day hospital stay waiver (support) and other COVID-19 PHE regulatory flexibilities.
Urge Congress to legislatively waive Statutory Pay-As-You-Go Medicare sequester triggered by H.R. 1.
Discuss with Congressional staff opposition to Medicaid policies in H.R.1: work requirements as a condition of coverage, changes to state-directed payments, reductions to Federal matching funds, reductions to the safe harbor threshold for provider taxes, sunset of broad-based and uniform provider tax waivers, rescission of Medicaid Eligibility rule and Medicaid/CHIP Access rule, reductions to retroactive coverage.
Discuss support for three-year phase-out of non-broad-based and uniform Medicaid provider tax waivers included in H.R. 1 with Congress, CMS staff, and CMS leadership.
Support certain changes to Medicaid DSH payments: support two-year elimination of Medicaid DSH cut; support Save Our Safety Net Hospitals Act to restore pre-CAA, 2021 DSH cap calculation methodology and include dual-eligible patients in state DSH cap calculation.
Discuss Medicaid Section 1115 waiver with Congressional staff and HHS.
Oppose proposed rule - Medicare and Medicaid Conditions of Participation: Limiting Participation Based on the Performance of Sex Trait Modification Procedures on Children with Congressional staff.
Discuss support for Emergency Medicaid with Congressional staff.
Discuss CMMI initiatives on global budgets and primary care in NYS Medicaid waiver.
Discuss Graduate Nurse Education demonstration with Congressional staff.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Alfredo |
|
|
|
Jonathan |
Cooper |
|
|
|
Genny |
Glembotzky |
|
|
|
Timothy |
Johnson |
|
|
|
Puja |
Khare |
|
|
|
Emily |
Leish |
|
|
|
Kenneth |
Raske |
|
|
|
Elisabeth |
Wynn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Discuss Medicare GME funding in CAA, 2021 and CAA, 2023 with Congressional staff and HHS staff.
Support health extenders in H.R. 5371, Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026: extend COVID-19 Medicare-covered telehealth flexibilities, Acute Hospital Care at Home waiver, Medicaid DSH cut delay; discuss with Congressional staff and HHS staff.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Alfredo |
|
|
|
Jonathan |
Cooper |
|
|
|
Genny |
Glembotzky |
|
|
|
Timothy |
Johnson |
|
|
|
Puja |
Khare |
|
|
|
Emily |
Leish |
|
|
|
Kenneth |
Raske |
|
|
|
Elisabeth |
Wynn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Oppose September 19 Presidential Proclamation imposing $100,000 fee on employers petitioning for new H-1B visas; advocate for health care sector exemption.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jonathan |
Cooper |
|
|
|
Genny |
Glembotzky |
|
|
|
Timothy |
Johnson |
|
|
|
Kenneth |
Raske |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |